Skip to content
DefDex

Federal award

CLEVELAND BIOLABS, INC.

W9113M10C0088

Contract

Obligated and Ceiling

Obligated (net)
$6,957,150.89
Ceiling (potential value, not spending)
$48,229,011.30
Current value
$8,317,440.30
Gross positive obligations
$6,973,681.30

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
CLEVELAND BIOLABS, INC. · J223MEGF2LP1
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
CLEVELAND BIOLABS, INC. · J223MEGF2LP1
Awarding agency
Department of War · sub-agency 2100 · office W911QY
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Industry (NAICS)
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PIID
W9113M10C0088
Award type code
D
Actions
14 · Sep 16, 2010 to Sep 10, 2019
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History14

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 10, 2019FY2019P00013M−$16,530.41
—
Mar 16, 2014FY2014P00012M$0.00
—
Jan 16, 2014FY2014P00011G$39,920.30
—
Dec 31, 2013FY2014P00010M$0.00
—
Dec 23, 2013FY2014P00009D$0.00
—
Dec 13, 2013FY2014P00008D$0.00
—
Sep 30, 2013FY2013P00007D$0.00
—
Oct 23, 2012FY2013P00006D$0.00
—
Jun 23, 2011FY2011P00005B$0.00
—
Apr 14, 2011FY2011P00004M$0.00
—
Mar 11, 2011FY2011P00003C$1,541,895.00
—
Dec 14, 2010FY2011P00002M$0.00
—
Sep 17, 2010FY2010P00001M$0.00
—
Sep 16, 2010FY20100—$5,391,866.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.